BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 16, 2005
View Archived Issues
Combining 5-HT6 and 5-HT2A antagonists improves both psychotic and cognitive deficits in rats
Read More
Conessine derivatives antagonize human H3 receptors and penetrate BBB
Read More
Novel CDK inhibitor from Roche
Read More
Apixaban enters phase II/III trials as a preventive therapy for venous and pulmonary thrombosis
Read More
Avalon and Novartis collaborate on drug discovery
Read More
Pharmacokinetic profile of NBI-12i in rats
Read More
Phase I study to begin for Cardio Vascu-Grow in diabetic wounds
Read More
Phase II protocol submitted for Davanat/5-FU in cholangiocarcinoma
Read More
Indaflex studied in phase II trial for osteoarthritis of the knee
Read More
Clearance for phase II study of topical interferon alpha-2b in ano-genital warts
Read More
Calcium-sensing receptor (CaSR) validated as a target for bladder dysfunction
Read More
Glucosylceramide synthase inhibitor suppresses tumor growth in vivo
Read More
Hybridon changes name to Idera
Read More
Abatacept demonstrates sustained efficacy in rheumatoid arthritis
Read More
Amantadine shows efficacy in preventing weight gain associated with olanzapine therapy
Read More
Bicifadine induces significant pain relief after bunionectomy
Read More
Pfizer completes acquisition of Vicuron
Read More
MedImmune to acquire Cellective Therapeutics
Read More
Phase II trial of TNX-355 for HIV recommended to continue
Read More
Alzhemed begins European phase III trial
Read More
Synta begins phase IIb trial of STA-5326 in active Crohn's disease
Read More
Private financing to support preclinical development of Riotech's IFN-alpha-8
Read More
Calpain inhibitors disclosed as potential agents for DMD/News in Context
Read More
Method of risk assessment for autism described in recent patent literature
Read More
Agents for arthritis and other inflammatory conditions revealed in patent literature
Read More
Plant extracts demonstrate antidiabetic activity
Read More
CTCE-0214 supports stem-cell expansion and engraftment
Read More
Bexel Pharmaceuticals presents new data on their antidiabetic candidates
Read More
Positive opinion issued for Naglazyme for MPS VI in Europe
Read More
NovoLog approved for use in children
Read More
FDA expands Neulasta label
Read More